InterCure Ltd
INCR
View Detailed Chart
0.733USD
+0.003+0.40%
Close 03/30, 16:00（ET）Quotes delayed by 15 min
280.44Market Cap
LossP/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
+0.40%
5 Days
-5.26%
1 Month
-11.69%
6 Months
-53.01%
Year to Date
-19.45%
1 Year
-48.01%
View Detailed Chart
TradingKey Stock Score of InterCure Ltd
Currency: USD Updated: 2026-03-27Key Insights
InterCure Ltd's fundamentals are relatively healthy, with an industry-leading ESG disclosure.and its growth potential is significant.Its valuation is considered undervalued, ranking 62 out of 75 in the Healthcare Providers & Services industry.Institutional ownership is very high.In the medium term, the stock price is expected to trend down.Despite a weak stock market performance over the past month, the company shows strong technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
InterCure Ltd's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
InterCure Ltd Highlights
StrengthsRisks
InterCure Ltd is an Israel-based company primarily enagged in cannabis industry. Thorugh its wholly owned subsidiary Canndoc the Company operates as licensed cannabis producer and one of the first to offer Good Manufacturing Practices (GMP) certified and pharmaceutical-grade medical cannabis products.
Growing
The company is in a growing phase, with the latest annual income totaling USD 66.10M.
Overvalued
The company’s latest PE is -2.01, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 2.13M shares, decreasing 30.97% quarter-over-quarter.
Analyst Rating
Based on
0
analysts
--
Current Rating
--
Target Price
--
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
InterCure Ltd News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
InterCure Ltd Info
InterCure Ltd is an Israel-based company primarily enagged in cannabis industry. Thorugh its wholly owned subsidiary Canndoc the Company operates as licensed cannabis producer and one of the first to offer Good Manufacturing Practices (GMP) certified and pharmaceutical-grade medical cannabis products.
Ticker SymbolINCR
CompanyInterCure Ltd
CEOMimon (Ori)
Websitehttps://www.intercure.co/
Related Instruments
-2.33%
-2.53%
-1.80%
-3.36%
-2.57%
-2.22%
-1.97%
-3.21%
-2.20%
-1.48%
-10.33%
-2.55%
-5.16%
-2.85%
+0.97%
-3.15%
-1.28%
-1.06%
-1.09%
-1.75%Popular Symbols
246.650
-6.240 (-2.47%)
165.060
-2.460 (-1.47%)
66636.600
+52.550 (+0.08%)
251.665
-21.685 (-7.93%)
2023.650
+23.650 (+1.18%)
355.270
-16.840 (-4.53%)
4510.490
+17.970 (+0.40%)
104.222
+3.613 (+3.59%)
1.146
-0.005 (-0.40%)
159.718
-0.534 (-0.33%)
